NFO period: 25^th June - 09^th July, 2018

Highlights of the NFO:

• Scheme type - An open ended equity scheme following Pharma, Healthcare, Diagnostic and allied Theme


• Investment objective - To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objective of the scheme would be achieved.


• Product suitability - The product is suitable for investors who are seeking long term wealth creation an equity scheme that predominantly by investing in pharma, healthcare, hospitals, diagnostics, wellness and allied companies.


• Minimum Application Amount - First investment is Rs. 5,000/- and in multiples of Rs. 1/- thereafter


• Plan/ Options available - Direct Plan having Growth Option and Dividend Option with Dividend Payout and Dividend Reinvestment facility.


• Fund Manager - Mr. Ihab Dalwai and Ms. Priyanka Khandelwal


• Benchmark - S&P BSE Healthcare Index